Reactivation of tuberculosis is associated with a shift from type 1 to type 2 cytokines

Clinical and Experimental Immunology

Volumn 115, Issue 3, 1999, Pages 428-434

  Howard, A D ^a   Zwilling, Bruce S ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Latent tuberculosis; Reactivation; Tuberculosis; Type 1 and type 2 cytokines

Indexed keywords

CD45 ANTIGEN; CYTOKINE; GAMMA INTERFERON; HERMES ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LYMPHOTOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; CYTOKINE RELEASE; HORMONE SENSITIVITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; LUNG TUBERCULOSIS; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; T LYMPHOCYTE SUBPOPULATION; TUBERCULOSIS CONTROL;

ANIMALS; ANTIGENS, CD44; ANTIGENS, CD45; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; LUNG; MALE; MICE; MICE, INBRED BALB C; PITUITARY-ADRENAL SYSTEM; RECURRENCE; T-LYMPHOCYTE SUBSETS; TUBERCULOSIS, PULMONARY;

EID: 0032994328     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00791.x     Document Type: Article

References (69)

1. Bloom BR. Tuberculosis, back to the frightening future. Science 1992; 358:538-9.
2. Bloom BR, Flynn J, McDonough K, Kress Y, Chan J. Experimental approaches to mechanisms of protection and pathogenesis in M. tuberculosis infection. Immunobiol 1994; 191:526-36.
3. Boom WH, Wallis RS, Chervenak KA. Human Mycobacterium tuberculosis reactive CD4+ T-cell clones: heterogeneity in antigen recognition, cytokinc production, and cytotoxicity for mononuclear phagocytes. Infect Immun 1991; 59:2737-43.
4. Cooper AM, Flynn JL. The protective immune response to Mycobacterium tuberculosis. Curr Opin Immunol 1995; 7:512-6.
5. Ellner JJ. Regulation of the human immune response during tuberculosis. J Lab Clin Med 1997; 130:469-75.
6. Hopewell PC. Overview of clinical tuberculosis. In: Bloom BR, ed. Tuberculosis: pathogenesis, protection and control. Washington DC: ASM Press., 1994:25-46.
7. Kaufmann SHE. Tuberculosis. The role of the immune respond. The Immunologist 1993; 1:109-14.
8. Orme IM. Characteristics and specificity of acquired immunologic memory to Mycobacterium tuberculosis infection. J Immunol 1988; 140:3589-93.
9. Orme IM. Protective and memory immunity in mice infected with Mycobacterium tuberculosis. Immunobiol 1994; 191:503-8.
10. Orme IM, Roberts AD, Griffin JP, Abrams JS. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J Immunol 1993; 151:518-25.
11. Rook GAW. Macrophages and Mycobacterium tuberculosis. The key to pathogenesis. In: Zwilling BS, Eisenstein TK, eds. Macrophage pathogen interactions. New York: Marcel Dekker, Inc., 1094:249-61.
12. Rook GAW, Bloom BR. Mechanisms of pathogenesis in tuberculosis. In: Bloom BR, ed. Tuberculosis: pathogenesis, protection and control Washington DC: ASM Press, 1994:485-501.
13. Smith PG, Moss AR. Epidemiology of tuberculosis. In: Bloom BR, ed. Tuberculosis: pathogenesis, protection and control. Washington DC: ASM Press, 1994:47-59.
14. Snider DE Jr, Raviiglione M, Kochi A. Global burden of tuberculosis. In: Bloom BR, ed. Tuberculosis: pathogenesis, protection and control. Washington DC: ASM Press, 1994:3-11.
15. Wayne LG. Dormancy of Mycobacterium tuberculosis and latency of disease.. Eur J Clin Microbiol 1994; 13:908-14.
16. Collins FM. Mycobacterial disease, immune suppression and acquired immunodeficiency syndrome. Clin Microbiol Rev 1989; 2:360-77.
17. Sheridan JF, Dobbs C, Brown D, Zwilling BS. Psychoneuroimmunology: stress effects on pathogenesis and immunity during infection. Clin Microbiol Rev 1994; 7:202-12.
18. Smith DW, Wiegeshaus EH, Edwards ML. The protective effects of BCG vaccination against tuberculosis. In: Bendinelli M, Friedman H, eds. Mycobacterium tuberculosis: interactions with the immune system. New York: Plenum Press, 1988:341-70.
19. Wiegeshaus E, Balasubramanian V, Smith DW. Immunity to tuberculosis from the perspective of pathogenesis. Infect Immun 1989; 57:3671-6.
20. Conradt P, Kaufmann SHE. Impact of antigen presenting cells on cytokine profiles of human Th clones established after stimulation with Mycobacterium tuberculosis antigens. Infect Immun 1995; 63:2079-81.
21. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993; 178:2240-54.
22. Wallis RS, Ellner JJ. Cytokines and tuberculosis. J Leuk Biol 1994; 55:676-81.
23. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in intererferon-γ gene-disrupted mice. J Exp Med 1993; 178:2243-7.
24. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Brakley A, Stewart TA. Multiple defects of cell function in mice with disrupted interferon-γ genes. Science 1993; 259:1739-45.
25. Flynn JL, Goldstein MM, Triebold KJ, Koller B, Bloom BR. Major histocompatibility complex class I restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 1992; 89:12013-7.
26. Kamijo R, Le J, Shapiro D, Havell EA, Huang S, Aguet M, Bosland M, Vilcek J. Mice that lack the interferon-γ receptor have profoundly altered responses to infection with Bacillus-Calmette-Guerin and subsequent challenge with lipopolysaccharide. J Exp Med 1993; 178:1435-40.
27. Kaufmann SHE, Ladel CH. Role of T cell subsets in immunity against intracellular bacteria: experimental infections of knock-out mice with Listeria monocytogenes and Mycobacterium boris BCG. Immunobiol 1994; 191:509-19.
28. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383:787-93.
29. Mosmann TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 1989; 7:145-73.
30. O'Garra A, Murphy K. Role of cytokines in determining T lymphocyte function. Curr Opinion Immunol 1994; 6:458-66.
31. McKisic MD, Lancki DW, Fitch FW. Cytolytic activity of murine CD4+ T cell clones correlates with IFN-γ production in mouse strains having a BALB/c background. J Immunol 1993; 150:3793-805.
32. Pearse EJ, Reiner SL. Induction of Th2 responses in infectious diseases. Curr Opin Immunol 1995; 7:497-504.
33. Tsukaguchi K, Balaji KN, Boom WH. CD4+ αβ T cell and γδ T cell response to Mycobacterium tuberculosis. Similarities and differences in Ag recognition, cytotoxic effector function and cytokine production. J Immunol 1995; 154:1786-96.
34. Wang Z-E, Reiner SL, Zheng S, Dalton DK, Locksley RM. CD4+ effector cells default to the Th2 pathway in interferon γ-deficient mice infected with Leishmania major. J Exp Med 1994; 179:1367-71.
35. Brown DH, Sheridan JF, Pearl D, Zwilling BS. Regulation of mycobacterial growth by the hypothalamus-pituitary-adrenal axis: differential responses of Mycobacterium bovis BCG-resistant and susceptible mice. Infect Immun 1993; 61:4793-800.
36. Howard AD, Trask OJ, Weisbrode SE, Zwilling BS. Phenotypic changes in T cell populations during the reactivation of tuberculosis in mice. Clin Exp Immunol 1998; 111:309-15.
37. Croft M, Duncan DD, Swain SL. Response of naive antigen specific CD4+ T cells in vitro: characteristics and antigen presenting cell requirements. J Exp Med 1994; 176:1431-7.
38. Croft M, Bradley LM, Swain SL. Naive versus memory CD4 T cells response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to any antigen presenting cell types including resting B cells. J Immunol 1994; 152:2675-85.
39. Croft M, Carter L, Swain SL, Dutton RW. Generation of polarized antigen-specific CD8 effector populations: reciprocal actions of interleukin (IL) 4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J Exp Med 1994; 180:1715-28.
40. Howard AD, Zwilling BS. Cytokine production by CD4 and CD8 T cells during the growth of Mycobacterium tuberculosis in mice. Clin Exp Immunol 1998; 113:443-9.
41. Saunders BM, Cheers C. Inflammatory response following intranasal infection with Mycobacterium avium complex: role of T cell subsets and gamma interferon. Infect Immun 1995; 63:2282-7.
42. Brown DH, Zwilling BS. Activation of the hypothalamic-pituitary-adrenal axis differentially affects the anti-mycobacterial activity of macrophages from BCG resistant and susceptible mice. J Neuroimmunol 1994; 53:181-7.
43. Brown DH, Miles BA, Zwilling BS. Growth of Mycobacterium tuberculosis in BCG resistant and susceptible mice: establishment of latency and reactivation. Infect Immun 1995; 63:2243-7.
44. Andersen P, Andersen AB, Sorensen AL, Nagai S. Recall of longed lived immunity to Mycobacterium tuberculosis. J Immunol 1995; 154:3359-72.
45. Griffin JP, Orme IM. Evolution of CD4 T cell subsets following infection of naive and memory immune mice with Mycobacterium tuberculosis. Infect Immun 1994; 62:1683-90.
46. Flesch IEA, Hess JH, Huang S, Aguet M, Rothe J, Bluethmann H, Kaufmann SHE. Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon γ and tumor necrosis factor α. J Exp Med 1995; 181:1615-21.
47. Flynn JL, Goldstein MM, Chan J et al. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995; 2:561-72.
48. Hernandez-Pando R, Rook GAW. The role of TNF-α in T cell mediated inflammation depends on the Th1/Th2 cytokine balance. Immunology 1994; 82:591-5.
49. Mutis T, Kraakman EM, Cornelisse YE, Haanen JBAG, Spits H, DeVries RRP, Ottenhoff THM. Analysis of cytokine production by Mycobacterium-reactive T cells. J Immunol 1993; 150:4641-51.
50. Torres M, Herrera T, Villareal H, Rich EA, Sada E. Cytokine profiles for peripheral blood lymphocytes from patients with active pulmonary tuberculosis and healthy household contacts in response to the 30 kilodalton antigen of Mycobacterium tuberculosis. Infect Immun 1998; 66:176-80.
51. Zhang M, Gong J, Iyer DV, Jones BE, Modlin RI., Barnes PF. T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. J Clin Invest 1994; 94:2435-42.
52. Micallef MJ, Ohtsuki T, Kohno K et al. Interferon-gamma-inducing factor enhances T helper I cytokine production by stimulated human T cells: synergism with interleukin 12 for interferon gamma production. Eur J Immunol 1996; 26:1647-51.
53. Hernandez-Pando R, Orozcoe H, Sampier A, Pavon L, Velasquillo C, Larriva-Sahd J, Alcocer JM, Madrid MV. Correlation between the kinetics of Th1/Th2 cells and pathology in a murine model of experimental pulmonary, tuberculosis. Immunology 1996; 89:26-33.
54. Barnes PJ. Anti-inflammatory mechanisms of glucocorticoids. Biochem Soc Trans 1995; 23:940-5.
55. Brunetti M, Martelli N, Colasante A, Piantelli M, Musiani P, Aiello FB. Spontaneous and glucocorticoid induced apoptosis in human mature T lymphocytes. Blood 1995; 86:4199-205.
56. Norimatsu M, Ono T, Aoki A, Ohishi K, Tamura Y. In vivo induction of apoptosis in murine lymphocytes by bacterial lipopolysaccharide. J Med, Microbiol 1995; 43:251-7.
57. Oldenburg NB, Evans-Storms RB, Cidlowski JA. In vivo resistance to glucocorticoid induced apoptosis in rat thymocytes with normal steroid receptor function in vitro. Endocrinology 1997; 138:810-8.
58. Tusoto L, Mundari E, Montani MS, Piccolclla E. Analysis of susceptibility of mature human T lymphocytes to dexamethasone-induced apoptosis. Eur J Immunol 1994; 24:1061-5.
59. Brinkman V, Kristofic C. Regulation by corticosteroids of Th1 and Th2 cytokine production in human CD4+ effector T cells generated from CD45RO- and CD45RO+ subsets. J Immunol 1995; 155:3322-8.
60. Daynes RA, Meikle AW, Araneo BA. Locally active steroid hormones may facilitate compartmentalization of immunity by regulating the types of lymphokines produced by helper T cells. Res Immunol 1991; 142:40-45.
61. Alleva DG, Kaser SB, Monroy MA, Fenton MJ, Beller DJ. IL-15 functions as a potent autocrine regulator of macrophage proinflammatory cytokine production: evidence for differential receptor subunit utilization associated with stimulation or inhibition. J Immunol 1997; 159:2941-51.
62. Carson WE, Fehniger TA, Haldar S et al. A potential role for interleukin-15 in the regulation of human natural killer cell survival. J Clin Invest 1997; 99:937-43.
63. Chae DW, Nosaka Y, Strom TB, Maslinski W. Distribution of IL-15 receptor alpha-chains on human peripheral blood mononuclear cells and effect of immunosuppressive drugs on receptor expression. J Immunol 1996; 157:2813-9.
64. Jullien D, Sieling PA, Uyemura K, Mar ND, Rea TH, Modlin RL. IL-15, an immunomodulator of T cell responses in intracellular infection. J Immunol 1997; 158:800-6.
65. Chensue SW, Ruth JH, Warmington K, Lincoln P, Kunkel SL. In vivo regulation of macrophage IL-12 production during type 1 and type 2 cytokinemediated granuloma formation. J Immunol 1995; 155:3546-51.
66. Flynn JL, Goldstein MM, Triebold KJ, Sypek J, Wolf S, Bloom BR. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J Immunol 1995; 155:2515-24.
67. Kamogawa Y, Minasi L-AE, Carding SR, Bottomly K, Flavell RA. The relationship of IL-4 and IFNγ,-producing T cells studied by lineage ablation of IL-4 producing cells. Cell 1993; 75:985-95.
68. Manetti R, Gerosa F, Giudizi MG et al. Interleukin 12 induces stable priming for interferon γ (IFN-γ) production during differentiation of human T helper (Th) cells and transient IFN-γ production in established Th2 cell clones. J Exp Med 1994; 179:1273-83.
69. Szabo SJ, Jacobson NG, Dighe AS, Gubler U, Murphy KM. Development commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity 1995; 2:665-75.